30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

ACADIA Pharmaceuticals Inc (ACAD)

Track

Over the last 90 days, ACADIA Pharmaceuticals Inc. has seen 15 insider transactions, all of which were sales totaling over $1 million. Notably, the CEO and CFO have been among the sellers. This activity occurred following a recent earnings report where the company missed expectations.
Stock chart
Ticker: ACAD Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Kihara James
PRINCIPAL ACCOUNTING OFFICER
1 sale — total 114,393 USD
Planned sale 26 May 2026
Value US$1,218,195.10 | Price 384.94 | Shares 93,323
Proposed sale 26 May 2026
Value US$4,218,602.27 | Price 119.78 | Shares 44,225
Planned sale 4 May 2026
Value US$29,024.28 | Price 21.79 | Shares 1,332
Planned sale 4 May 2026
Value US$76,395.74 | Price 21.79 | Shares 3,506
Planned sale 7 Apr 2026
Value US$60,139.80 | Price 22.20 | Shares 2,709
Planned sale 7 Apr 2026
Value US$22,866.00 | Price 22.20 | Shares 1,030
Planned sale 26 Mar 2026
Value US$803.54 | Price 21.72 | Shares 37
Planned sale 26 Mar 2026
Value US$68,652.15 | Price 21.65 | Shares 3,171
Planned sale 26 Mar 2026
Value US$260.70 | Price 21.73 | Shares 12
Planned sale 26 Mar 2026
Value US$23,750.05 | Price 21.65 | Shares 1,097
Planned sale 25 Mar 2026
Value US$89,680.19 | Price 21.47 | Shares 4,177
Planned sale 25 Mar 2026
Value US$249,932.27 | Price 21.47 | Shares 11,641
Planned sale 25 Mar 2026
Value US$73,749.45 | Price 21.47 | Shares 3,435
Planned sale 25 Mar 2026
Value US$82,530.68 | Price 21.47 | Shares 3,844
Planned sale 25 Mar 2026
Value US$17,884.51 | Price 21.47 | Shares 833
Planned sale 9 Feb 2026
Value US$162,491.00 | Price 23.38 | Shares 6,950
Planned sale 18 Nov 2025
Value US$96,753.64 | Price 23.69 | Shares 4,084
Planned sale 18 Nov 2025
Value US$243,113.96 | Price 23.69 | Shares 10,262
Sale 10 Nov 2025
Value US$670,983.00 | Price 22.37 | Shares 30,000
Proposed sale 10 Nov 2025
Value US$670,983.00 | Price 22.37 | Shares 30,000
Planned sale 15 Sep 2025
Value US$82,727.70 | Price 23.65 | Shares 3,498
Sale 2 Sep 2025
Value US$41,560.48 | Price 25.98 | Shares 1,600
Planned sale 18 Aug 2025
Value US$554,023.80 | Price 25.18 | Shares 22,000
Proposed sale 18 Aug 2025
Value US$557,260.00 | Price 25.33 | Shares 22,000
Sale 4 Jun 2025
Value US$314,633.88 | Price 21.78 | Shares 14,446
Proposed sale 4 Jun 2025
Value US$314,638.21 | Price 21.78 | Shares 14,446
Planned sale 16 May 2025
Value US$40,000.00 | Price 20.00 | Shares 2,000
Planned sale 16 May 2025
Value US$50,000.00 | Price 25.00 | Shares 2,000
Proposed sale 16 May 2025
Value US$70,400.00 | Price 17.60 | Shares 4,000
Planned sale 16 May 2025
Value US$50,000.00 | Price 25.00 | Shares 2,000
Proposed sale 16 May 2025
Value US$35,200.00 | Price 17.60 | Shares 2,000
Planned sale 2 May 2025
Value US$19,374.20 | Price 14.60 | Shares 1,327
Planned sale 2 May 2025
Value US$51,070.80 | Price 14.60 | Shares 3,498
Planned sale 8 Apr 2025
Value US$40,132.56 | Price 14.82 | Shares 2,708
Planned sale 8 Apr 2025
Value US$15,234.96 | Price 14.82 | Shares 1,028
Planned sale 26 Mar 2025
Value US$18,669.75 | Price 17.05 | Shares 1,095
Planned sale 26 Mar 2025
Value US$54,065.55 | Price 17.05 | Shares 3,171
Proposed sale 5 Mar 2025
Value US$89,673.37 | Price 18.23 | Shares 4,919
Sale 5 Mar 2025
Value US$89,673.37 | Price 18.23 | Shares 4,919
Planned sale 24 Feb 2025
Value US$9,481.00 | Price 19.96 | Shares 475
Planned sale 24 Feb 2025
Value US$15,429.08 | Price 19.96 | Shares 773
Planned sale 19 Nov 2024
Value US$172,453.79 | Price 16.81 | Shares 10,259
Planned sale 19 Nov 2024
Value US$173,630.49 | Price 16.81 | Shares 10,329
Planned sale 19 Nov 2024
Value US$68,467.13 | Price 16.81 | Shares 4,073
Planned sale 19 Aug 2024
Value US$485,094.16 | Price 15.28 | Shares 31,747
Planned sale 19 Aug 2024
Value US$148,720.24 | Price 15.28 | Shares 9,733
Planned sale 19 Aug 2024
Value US$145,679.52 | Price 15.28 | Shares 9,534
Planned sale 10 Jun 2024
Value US$14,420.25 | Price 14.79 | Shares 975
Planned sale 2 May 2024
Value US$58,900.38 | Price 16.94 | Shares 3,477
Planned sale 2 May 2024
Value US$22,462.44 | Price 16.94 | Shares 1,326
Planned sale 2 May 2024
Value US$193,573.38 | Price 16.94 | Shares 11,427
Planned sale 2 May 2024
Value US$59,340.82 | Price 16.94 | Shares 3,503
Planned sale 8 Apr 2024
Value US$48,534.92 | Price 17.87 | Shares 2,716
Planned sale 8 Apr 2024
Value US$316,584.92 | Price 17.87 | Shares 17,716
Planned sale 8 Apr 2024
Value US$158,292.46 | Price 17.87 | Shares 8,858
Planned sale 8 Apr 2024
Value US$45,890.16 | Price 17.87 | Shares 2,568
Planned sale 8 Apr 2024
Value US$13,616.94 | Price 17.87 | Shares 762
Planned sale 8 Apr 2024
Value US$18,370.36 | Price 17.87 | Shares 1,028
Planned sale 27 Mar 2024
Value US$97,268.60 | Price 17.90 | Shares 5,434
Planned sale 27 Mar 2024
Value US$317,080.60 | Price 17.90 | Shares 17,714
Planned sale 27 Mar 2024
Value US$92,006.00 | Price 17.90 | Shares 5,140
Planned sale 26 Feb 2024
Value US$19,045.24 | Price 24.67 | Shares 772
Planned sale 26 Feb 2024
Value US$137,584.59 | Price 24.67 | Shares 5,577
Planned sale 26 Feb 2024
Value US$11,693.58 | Price 24.67 | Shares 474
Planned sale 26 Feb 2024
Value US$15,394.08 | Price 24.67 | Shares 624
Sale 8 Jan 2024
Value US$21,900.76 | Price 29.96 | Shares 731
Sale 8 Jan 2024
Value US$17,676.40 | Price 29.96 | Shares 590
Sale 8 Jan 2024
Value US$111,810.72 | Price 29.96 | Shares 3,732
Proposed sale 15 Dec 2023
Value US$56,120.00 | Price 28.06 | Shares 2,000
Planned sale 15 Dec 2023
Value US$56,600.00 | Price 28.30 | Shares 2,000
Sale 20 Nov 2023
Value US$44,940.40 | Price 22.64 | Shares 1,985
Sale 20 Nov 2023
Value US$112,294.40 | Price 22.64 | Shares 4,960
Sale 20 Nov 2023
Value US$115,645.12 | Price 22.64 | Shares 5,108
Sale 6 Oct 2023
Value US$1,132,323.48 | Price 21.96 | Shares 51,563
Sale 6 Oct 2023
Value US$359,463.24 | Price 21.96 | Shares 16,369
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-27 2026-05-26 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
93,323 -0.2%
384.94
US$1,218,195 		93,323 -0.2% 384.94 US$1,218,195
2026-05-26 2026-05-26 PrS Proposed sale
2.3
JAMES K KIHARA

Officer

Officer
44,225
119.78
US$4,218,602 		44,225 119.78 US$4,218,602
2026-05-05 2026-05-04 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
87,830 -26.5%
239.05
US$2,864,175 		87,830 -26.5% 239.05 US$2,864,175
2026-05-05 2026-05-04 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
3,506 -5.0%
21.79
US$76,396 		3,506 -5.0% 21.79 US$76,396
2026-04-07 2026-04-07 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
2,709 -4.1%
22.20
US$60,140 		2,709 -4.1% 22.20 US$60,140
2026-04-07 2026-04-07 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
1,030 -3.6%
22.20
US$22,866 		1,030 -3.6% 22.20 US$22,866
2026-03-26 2026-03-26 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
37 -0.1%
21.72
US$804 		37 -0.1% 21.72 US$804
2026-03-26 2026-03-26 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
3,171 -5.0%
21.65
US$68,652 		3,171 -5.0% 21.65 US$68,652
2026-03-26 2026-03-26 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
12 -0.0%
21.73
US$261 		12 -0.0% 21.73 US$261
2026-03-26 2026-03-26 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
1,097 -3.9%
21.65
US$23,750 		1,097 -3.9% 21.65 US$23,750
2026-03-26 2026-03-25 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
4,177 -6.8%
21.47
US$89,680 		4,177 -6.8% 21.47 US$89,680
2026-03-26 2026-03-25 PlS Planned sale
Owen Adams Catherine

Chief Executive Officer

Executive Director
11,641 -44.0%
21.47
US$249,932 		11,641 -44.0% 21.47 US$249,932
2026-03-26 2026-03-25 PlS Planned sale
Thompson Elizabeth H.Z.

EVP, Head of Research & Dev

Officer
3,435 -51.2%
21.47
US$73,749 		3,435 -51.2% 21.47 US$73,749
2026-03-26 2026-03-25 PlS Planned sale
3.4
Rhodes Jennifer J

EVP, CHIEF LEGAL OFFICER, SEC

Officer
3,844 -25.4%
21.47
US$82,531 		3,844 -25.4% 21.47 US$82,531
2026-03-26 2026-03-25 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
833 -3.1%
21.47
US$17,885 		833 -3.1% 21.47 US$17,885
2026-02-10 2026-02-09 PlS Planned sale
3.4
Rhodes Jennifer J

EVP, CHIEF LEGAL OFFICER, SEC

Officer
6,950 -47.7%
23.38
US$162,491 		6,950 -47.7% 23.38 US$162,491
2025-11-19 2025-11-18 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
4,084 -14.0%
23.69
US$96,754 		4,084 -14.0% 23.69 US$96,754
2025-11-19 2025-11-18 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
10,262 -16.1%
23.69
US$243,114 		10,262 -16.1% 23.69 US$243,114
2025-11-12 2025-11-10 S Sale
3.7
Daly James M
Non-Executive Director
30,000 -88.1%
22.37
US$670,983 		30,000 -88.1% 22.37 US$670,983
2025-11-10 2025-11-10 PrS Proposed sale
3.7
James M Daly

Director

Non-Executive Director
30,000
22.37
US$670,983 		30,000 22.37 US$670,983
2025-09-16 2025-09-15 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
3,498 -7.5%
23.65
US$82,728 		3,498 -7.5% 23.65 US$82,728
2025-09-03 2025-09-02 S Sale
3.1
GAROFALO ELIZABETH A.
Non-Executive Director
1,600 -5.9%
25.98
US$41,560 		1,600 -5.9% 25.98 US$41,560
2025-08-19 2025-08-18 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
22,000 -35.4%
25.18
US$554,024 		22,000 -35.4% 25.18 US$554,024
2025-08-18 2025-08-18 PrS Proposed sale
2.2
Schneyer Mark C.

Officer

Officer
22,000
25.33
US$557,260 		22,000 25.33 US$557,260
2025-06-05 2025-06-04 S Sale
3.1
Brege Laura
Non-Executive Director
14,446 -48.9%
21.78
US$314,634 		14,446 -48.9% 21.78 US$314,634
2025-06-04 2025-06-04 PrS Proposed sale
3.1
LAURA BREGE

Director

Non-Executive Director
14,446
21.78
US$314,638 		14,446 21.78 US$314,638
2025-05-19 2025-05-16 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
2,000 -8.9%
20.00
US$40,000 		2,000 -8.9% 20.00 US$40,000
2025-05-19 2025-05-16 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
2,000 -8.2%
25.00
US$50,000 		2,000 -8.2% 25.00 US$50,000
2025-05-19 2025-05-16 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
2,000 -3.1%
25.00
US$50,000 		2,000 -3.1% 25.00 US$50,000
2025-05-16 2025-05-16 PrS Proposed sale
2.2
Schneyer Mark C.

Officer

Officer
2,000
17.60
US$35,200 		2,000 17.60 US$35,200
2025-05-16 2025-05-16 PrS Proposed sale
2.3
Kihara James

Officer

Officer
4,000
17.60
US$70,400 		4,000 17.60 US$70,400
2025-05-02 2025-05-02 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
1,327 -5.3%
14.60
US$19,374 		1,327 -5.3% 14.60 US$19,374
2025-05-02 2025-05-02 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
3,498 -5.3%
14.60
US$51,071 		3,498 -5.3% 14.60 US$51,071
2025-04-08 2025-04-08 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
2,708 -4.4%
14.82
US$40,133 		2,708 -4.4% 14.82 US$40,133
2025-04-08 2025-04-08 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
1,028 -4.4%
14.82
US$15,235 		1,028 -4.4% 14.82 US$15,235
2025-03-26 2025-03-26 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
1,095 -4.9%
17.05
US$18,670 		1,095 -4.9% 17.05 US$18,670
2025-03-26 2025-03-26 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
3,171 -5.3%
17.05
US$54,066 		3,171 -5.3% 17.05 US$54,066
2025-03-06 2025-03-05 PrS Proposed sale
3.1
GAROFALO ELIZABETH A.

Director

Non-Executive Director
4,919
18.23
US$89,673 		4,919 18.23 US$89,673
2025-03-06 2025-03-05 S Sale
3.1
GAROFALO ELIZABETH A.
Non-Executive Director
4,919 -21.8%
18.23
US$89,673 		4,919 -21.8% 18.23 US$89,673
2025-02-25 2025-02-24 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
475 -2.3%
19.96
US$9,481 		475 -2.3% 19.96 US$9,481
2025-02-25 2025-02-24 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
773 -1.4%
19.96
US$15,429 		773 -1.4% 19.96 US$15,429
2024-11-19 2024-11-19 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
10,259 -16.1%
16.81
US$172,454 		10,259 -16.1% 16.81 US$172,454
2024-11-19 2024-11-19 PlS Planned sale
2.3
Teehan Brendan

EVP, COO, HEAD OF COMMERCIAL

Officer
10,329 -14.3%
16.81
US$173,630 		10,329 -14.3% 16.81 US$173,630
2024-11-19 2024-11-19 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
4,073 -17.0%
16.81
US$68,467 		4,073 -17.0% 16.81 US$68,467
2024-08-20 2024-08-19 PlS Planned sale
3.1
DAVIS STEPHEN

CEO

Executive Director
31,747 -14.5%
15.28
US$485,094 		31,747 -14.5% 15.28 US$485,094
2024-08-20 2024-08-19 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
9,733 -18.2%
15.28
US$148,720 		9,733 -18.2% 15.28 US$148,720
2024-08-20 2024-08-19 PlS Planned sale
2.3
Teehan Brendan

EVP, COO, HEAD OF COMMERCIAL

Officer
9,534 -15.4%
15.28
US$145,680 		9,534 -15.4% 15.28 US$145,680
2024-06-11 2024-06-10 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
975 -2.7%
14.79
US$14,420 		975 -2.7% 14.79 US$14,420
2024-05-03 2024-05-02 PlS Planned sale
2.3
Teehan Brendan

EVP, COO, HEAD OF COMMERCIAL

Officer
3,477 -7.6%
16.94
US$58,900 		3,477 -7.6% 16.94 US$58,900
2024-05-03 2024-05-02 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
1,326 -8.4%
16.94
US$22,462 		1,326 -8.4% 16.94 US$22,462
2024-05-03 2024-05-02 PlS Planned sale
3.1
DAVIS STEPHEN

CEO

Executive Director
11,427 -6.9%
16.94
US$193,573 		11,427 -6.9% 16.94 US$193,573
2024-05-03 2024-05-02 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
3,503 -9.9%
16.94
US$59,341 		3,503 -9.9% 16.94 US$59,341
2024-04-09 2024-04-08 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
2,716 -8.6%
17.87
US$48,535 		2,716 -8.6% 17.87 US$48,535
2024-04-09 2024-04-08 PlS Planned sale
3.1
DAVIS STEPHEN

CEO

Executive Director
17,716 -10.9%
17.87
US$316,585 		17,716 -10.9% 17.87 US$316,585
2024-04-09 2024-04-08 PlS Planned sale
3.1
DAVIS STEPHEN

CEO

Executive Director
8,858 -5.2%
17.87
US$158,292 		8,858 -5.2% 17.87 US$158,292
2024-04-09 2024-04-08 PlS Planned sale
2.3
Teehan Brendan

EVP, COO, HEAD OF COMMERCIAL

Officer
2,568 -6.2%
17.87
US$45,890 		2,568 -6.2% 17.87 US$45,890
2024-04-09 2024-04-08 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
762 -5.5%
17.87
US$13,617 		762 -5.5% 17.87 US$13,617
2024-04-09 2024-04-08 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
1,028 -6.9%
17.87
US$18,370 		1,028 -6.9% 17.87 US$18,370
2024-03-27 2024-03-27 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
5,434 -17.2%
17.90
US$97,269 		5,434 -17.2% 17.90 US$97,269
2024-03-27 2024-03-27 PlS Planned sale
3.1
DAVIS STEPHEN

CEO

Executive Director
17,714 -13.0%
17.90
US$317,081 		17,714 -13.0% 17.90 US$317,081
2024-03-27 2024-03-27 PlS Planned sale
2.3
Teehan Brendan

EVP, COO, HEAD OF COMMERCIAL

Officer
5,140 -12.4%
17.90
US$92,006 		5,140 -12.4% 17.90 US$92,006
2024-02-27 2024-02-26 PlS Planned sale
2.2
Schneyer Mark C.

EVP, CHIEF FINANCIAL OFFICER

Officer
772 -3.5%
24.67
US$19,045 		772 -3.5% 24.67 US$19,045
2024-02-27 2024-02-26 PlS Planned sale
3.1
DAVIS STEPHEN

CEO

Executive Director
5,577 -5.2%
24.67
US$137,585 		5,577 -5.2% 24.67 US$137,585
2024-02-27 2024-02-26 PlS Planned sale
2.3
Kihara James

PRINCIPAL ACCOUNTING OFFICER

Officer
474 -4.0%
24.67
US$11,694 		474 -4.0% 24.67 US$11,694
2024-02-27 2024-02-26 PlS Planned sale
2.3
Teehan Brendan

EVP, COO, HEAD OF COMMERCIAL

Officer
624 -1.9%
24.67
US$15,394 		624 -1.9% 24.67 US$15,394
2024-01-09 2024-01-08 S Sale
2.3
Teehan Brendan

EVP, COO, Head of Commercial

Officer
731 -2.3%
29.96
US$21,901 		731 -2.3% 29.96 US$21,901
2024-01-09 2024-01-08 S Sale
2.9
KIM AUSTIN D.

EVP,General Counsel, Secretary

Officer
590 -1.2%
29.96
US$17,676 		590 -1.2% 29.96 US$17,676
2024-01-09 2024-01-08 S Sale
3.1
DAVIS STEPHEN

CEO

Executive Director
3,732 -3.7%
29.96
US$111,811 		3,732 -3.7% 29.96 US$111,811
2023-12-15 2023-12-15 PrS Proposed sale
2.3
Kihara James

Officer

Officer
2,000
28.06
US$56,120 		2,000 28.06 US$56,120
2023-12-15 2023-12-15 PlS Planned sale
2.3
Kihara James

Principal Accounting Officer

Officer
2,000 -15.4%
28.30
US$56,600 		2,000 -15.4% 28.30 US$56,600
2023-11-21 2023-11-20 S Sale
2.3
Kihara James

Principal Accounting Officer

Officer
1,985 -13.2%
22.64
US$44,940 		1,985 -13.2% 22.64 US$44,940
2023-11-21 2023-11-20 S Sale
2.3
Teehan Brendan

EVP, COO, Head of Commercial

Officer
4,960 -14.0%
22.64
US$112,294 		4,960 -14.0% 22.64 US$112,294
2023-11-21 2023-11-20 S Sale
2.2
Schneyer Mark C.

EVP, Chief Financial Officer

Officer
5,108 -20.0%
22.64
US$115,645 		5,108 -20.0% 22.64 US$115,645
2023-10-06 2023-10-06 S Sale
3.1
DAVIS STEPHEN

CEO

Executive Director
51,563 -36.6%
21.96
US$1,132,323 		51,563 -36.6% 21.96 US$1,132,323
2023-10-06 2023-10-06 S Sale
2.9
KIM AUSTIN D.

EVP,General Counsel, Secretary

Officer
16,369 -26.3%
21.96
US$359,463 		16,369 -26.3% 21.96 US$359,463
Explore more

More insider trading research around ACADIA Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America